Abstract
Cardiovascular disease is the leading cause of death worldwide, which has encouraged the search for new therapies that enable the treatment of patients in palliative and curative ways. In the past decade, the potential benefit of transplantation of cells that are able to substitute for the injured tissue has been studied with several cell populations, such as stem cells. Some of these cell populations, such as myoblasts and bone marrow cells, are already being used in clinical trials. The laboratory of CM Verfaillie has studied primitive progenitors, termed multipotent adult progenitor cells, which can be isolated from adult bone marrow. These cells can differentiate in vitro at the single-cell level into functional cells that belong to the three germ layers and contribute to most, if not all, somatic cell types after blastocyst injection. This remarkably broad differentiation potential makes this particular cell population a candidate for transplantation in tissues in need of regeneration. Here, we focus on the regenerative capacity of multipotent adult progenitor cells in several ischemic mouse models, such as acute and chronic myocardial infarction and limb ischemia.
Key Points
-
Many embryonic and adult cell sources have been tested for their in vivo cardiomyogenic potential
-
The extent to which bone marrow cells differentiate to cardiomyocytes in the ischemic heart is still controversial
-
Multipotent adult progenitor cells comprise a bone marrow-derived adult stem cell population with multilineage differentiation capacity in vivo and in vitro
-
Acute and chronic cardiac ischemic hearts functionally improve after multipotent adult progenitor cell transplantation in rodent models
-
Multipotent adult progenitor cells can differentiate in vitro and in vivo into functional endothelial cells and contribute to vascular regeneration in mice with ischemic hearts or limbs
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chockalingam A et al. (2000) Prevention of cardiovascular diseases in developing countries: agenda for action (statement from a WHO-ISH Meeting in Beijing, October 1999). J Hypertens 18: 1705–1708
Beltrami AP et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763–776
Oh H et al. (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313–12318
Opie LH et al. (2006) Controversies in ventricular remodelling. Lancet 367: 356–367
Francis GS et al. (2003) Pathophysiology of congestive heart failure. Rev Cardiovasc Med 4 (Suppl 2): S14–2S0
Field LJ (2004) Modulation of the cardiomyocyte cell cycle in genetically altered animals. Ann NY Acad Sci 1015: 160–170
Gude N et al. (2006) Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res 99: 381–388
Bock-Marquette I et al. (2004) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432: 466–472
Masino AM et al. (2004) Transcriptional regulation of cardiac progenitor cell populations. Circ Res 95: 389–397
Rubart M et al. (2006) Cardiac regeneration: repopulating the heart. Annu Rev Physiol 68: 29–49
Koh GY et al. (1995) Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest 96: 2034–2042
Klug MG et al. (1996) Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 98: 216–224
Kolossov E et al. (2006) Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 203: 2315–2327
Sachinidis A et al. (2003) Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res 58: 278–291
Laflamme MA et al. (2005) Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167: 663–671
Vogel G. (2006) Cell biology. Picking up the pieces after Hwang. Science 312: 516–517
Priddle H et al. (2006) Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies. Stem Cells 24: 815–824
Siepe M et al. (2006) Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J Thorac Cardiovasc Surg 132: 124–131
Murry CE et al. (2005) Cell-based cardiac repair: reflections at the 10-year point. Circulation 112: 3174–3183
Makino S et al. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697–705
Orlic D et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701–705
Murry CE et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664–668
Balsam LB et al. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428: 668–673
Miyahara Y et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12: 459–465
Krause DS et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369–377
Grant MB et al. (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8: 607–612
Nygren JM et al. (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10: 494–501
Alvarez-Dolado M et al. (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425: 968–973
Jiang Y et al. (2003) Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci USA 100 (Suppl 1): 11854–11860
Jiang Y et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41–49
Reyes M et al. (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337–346
Reyes M et al. (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 2615–2625
Schwartz RE et al. (2002) Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109: 1291–1302
Tolar J et al. (2003) Multipotent adult progenitor cells (MAPCs) reduce glycosaminoglycan (GAG) accumulation in a murine model of Hurler syndrome (MPS 1H) [abstract 3115]. Session type. Blood 102
Muguruma Y et al. (2003) In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells. Exp Hematol 31: 1323–1330
Anjos-Afonso F and Bonnet D (2006) Non-hematopoietic/endothelial SSEA-1pos cells defines the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood Sep 26; Epub ahead of print
Kucia M et al. (2006) A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 20: 857–869
Nayernia K et al. (2006) Derivation of male germ cells from bone marrow stem cells. Lab Invest 86: 654–663
Agbulut O et al. (2006) Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovasc Res 72: 175–183
Tolar J et al. (2006) Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. Blood 107: 4182–4188
Pelacho B et al. (2005) Rodent multipotent adult progenitor cells (MAPC) can commit to a cardiac lineage [abstract]. Circulation 112 (Suppl 17S): 225
Acknowledgements
The work described in this review was supported by grants from Fondo de Investigaciones Sanitarias (PI042125), Ministerio de Ciencia y Tecnologia, Government of Navarra, FEDER (INTERREG IIIA), the “UTE project CIMA,” and the Excellentiefinanciering CMVB, KU Leuven (AL).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pelacho, B., Aranguren, X., Mazo, M. et al. Plasticity and cardiovascular applications of multipotent adult progenitor cells. Nat Rev Cardiol 4 (Suppl 1), S15–S20 (2007). https://doi.org/10.1038/ncpcardio0735
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0735